As recent directives like Most-Favored Nation come down from the government and competition increases, we’re at a turning point in how pharmaceutical companies interact with their patients. Gone are the days of minimal interaction, or primarily targeting providers and payers; now is the time for these organizations to become direct-to-patient (DTP).
As we’ve seen with Eli Lilly, Pfizer, and Novo Nordisk, BMS, and more, the industry is moving quickly towards this new frontier. Fullspan Health, an offering from RVO Health launched in August, expands direct-to-patient (DTP) and patient services capabilities for pharmaceutical companies and broader life sciences organizations.
Powered by RVO Health brands, we bring together the most comprehensive suite of capabilities and services in the industry to evolve and modernize the patient experience.
Our offering combines trusted data and content from our owned portfolio of health information sites, including Healthline, Medical News Today, and Psych Central, with tools such as the Healthgrades provider finder, prescription fulfillment, online care, support communities, and AI-driven care pathing. These capabilities ensure patients have the right resources and support at every step:
• Prior to diagnosis: Address concerns and explore solutions
Find a trusted place for personalized care, education, and understanding as the journey begins.
• At diagnosis and treatment: Access valuable support tools
Navigate treatment options, costs, side effects, and prescription fulfillment.
• Ongoing care management: Stay the course
Access lifestyle tools and services, community support, vetted wellness products, and more.
We at Fullspan Health can’t wait to partner with you to bring patients high-quality solutions for every moment of their health journey.